All too often, Katz sees patients skipping resistance training, under-eating protein and not hydrating sufficiently
Protein Snack Guidelines for GLP-1s Not all snacks are created equal when you're managing reduced appetite and GLP-1 side effects
4 ) Primary Clinical Applications Retatrutide Peptide is primarily studied as an additional treatment for long-term weight control in adults with obesity
These drugs are classed as glucagon-like peptide 1 receptor agonists, or GLP-1 RAs, the satiety hormone first developed to treat type 2 diabetes more than 20 years ago
Obesity has emerged as a global health crisis, with the World Obesity Federation projecting that over 4 billion individuals will be either obese or overweight by 2035
Presently, Retatrutide isn't part of any FDA-approved drug line and, thus, not available for purchase